TREE NEWS update: Since 2026, 17 biotech companies have listed on HKEX, raising HK$18.501 billion, accounting for 16.19% of the 105 new listings. Meanwhile, 110 biotech firms filed for Hong Kong IPOs this year, covering oncology, CGT, radiopharma, ophthalmology, and medical devices. A notable trend: many A-share drugmakers pursue dual listings, with some making repeated filings.
Biotech firms flock to Hong Kong IPO, ‘A+H’ listing favored
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
17m ago
China Logistics Prosperity Index Rises to 50.9% in August
30m ago
Uruguay declares health emergency over H5 bird flu
41m ago
Nepal landslide death toll rises to 1,342, 4,898 missing
49m ago
China’s Gyirong landslide donations top 660M yuan
58m ago
US Military Probes Leak of Advanced Weapons Stockpile Info
1h ago
US Judge Allows Pentagon to Fire Three Stars and Stripes Journalists